Guidance on evaluation fees for human drugs and disinfectants: Invoicing, fee payment and mitigation measures
Data and Resources
Additional Info
| Field | Value |
|---|---|
| Source | |
| Version | |
| Author | |
| Author Email | |
| Maintainer | |
| Maintainer Email | |
| Data Level | |
| Agreement Required | |
| Purpose Constraints | |
| Redistribution Allowed | |
| AI Training Allowed | |
| Data Steward | |
| Title (French) | Lignes directrices sur les frais d’évaluation des médicaments à usage humain et des désinfectants assimilés à une drogue : Facturation, paiement des frais et mesures d’atténuation |
| Update Frequency | as_needed |
| Geographic Scope | [] |
| Criticality Level | [] |
| Sensitivity Level | unrestricted |
| Language | |
| Contact Person | |
| Contact Email | |
| Data Dictionary | |
| Open Canada Date Published | 2023-02-08 00:00:00 |
| Open Canada Date Modified | |
| Open Canada Subject | ["health_and_safety"] |
| Open Canada Keywords | {"fr": ["présentations et demandes de médicaments", "présentation de médicaments pour humains et de désinfectants", "document d'orientation sur les frais", "frais d'examen", "frais d'évaluation", "facturation", "paiement des frais", "mesures d'atténuation"], "en": ["drug submissions-and-applications", "human-drugs-and-disinfectants submission", "guidance-document on fees", "fees for review", "evaluation fees", "invoicing", "fee payment", "mitigation measures"]} |
| Open Canada Collection | publication |
| Principal Organization | |
| Reference Data | |
| Official Source |